Prevail Therapeutics

430 E. 29th street
suite 940
New York
NY
10016
United States

Show jobs for this employer

About Prevail Therapeutics

Prevail Therapeutics is a biotechnology company focused on developing novel biologic therapies for Parkinson’s Disease and other neurodegenerative diseases. Prevail was launched in 2017 by The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO, and OrbiMed, and is headquartered in New York, NY. 

YEAR FOUNDED: 
2017 

LEADERSHIP: 
Founders: Silverstein Foundation for Parkinson’s with GBA, REGENXBIO, OrbiMed, and Asa Abeliovich

Currently there are no articles for this employer.

Check out their jobs by clicking the "Show Jobs" button to the left.